openPR Logo
Press release

Ankylosing Spondylitis (AS) Market – Key Players are Momenta Pharmaceuticals, Sandoz International GmbH, Pfizer Inc., Amgen Inc., Regeneron Pharmaceuticals, CELGENE CORPORATION

10-14-2019 07:53 AM CET | Health & Medicine

Press release from: Data Bridge Market Research

/ PR Agency: Data Bridge Market Research
Ankylosing Spondylitis Market Overview

Ankylosing Spondylitis Market Overview

This Global Ankylosing Spondylitis (AS) market research report potentially provides plentiful insights and business solutions that will lend a hand to win the competition. The report supports to establish and optimize each stage in the lifecycle of industrial process that includes engagement, acquisition, retention, and monetization. All statistical and numerical information given in the report is symbolized with the help of graphs and charts which facilitates the understanding of facts and figures. Ankylosing Spondylitis (AS) report has most-detailed market segmentation, systematic analysis of major market players, trends in consumer and supply chain dynamics, and insights about new geographical markets.

Global Ankylosing spondylitis (AS) Market is set to witness a substantial CAGR in the forecast period of 2019- 2026. The report contains data of the base year 2019 and historic year 2019. Increasing cases of ankylosing spondylitis worldwide and increasing healthcare expenditure is the factor for the growth of this market.

Market Definition: Global Ankylosing Spondylitis (AS) Market

Ankylosing spondylitis or AS is a kind of an arthritis which usually affect the spine of the patient by reducing the flexibility. This usually causes discomfort, pain, stiffness and inflammation. In some cases, spines get fused in fixed position due to new bone formation. Usually drugs such as nonsteroidal anti- inflammatory, TNF blockers, steroids, JAK inhibitors and others are used to treat this disease. This disease mainly creates stiffness in areas such as small joints, ribs, heels, hips and others. According to National Health and Nutritional Examination Survey (NHANES), in the U.S., 0.5 percent of the population or about 1.6 million people are affected by ankylosing spondylitis.

Download Sample Report @ https://databridgemarketresearch.com/request-a-sample/?dbmr=global-ankylosing-spondylitis-as-market

Besides, Ankylosing Spondylitis report also includes historic data, present and future market trends, environment, technological innovation, upcoming technologies and the technical progress in the related industry. The study conducted in this market report spans heterogeneous markets in accord with the requirement of Medical Devices industry and scoop out the best possible solutions and meticulous information about the market trends. With the study of competitor analysis, Medical Devices industry can get knowhow of the strategies of key players in the market that includes but are not limited to new product launches, expansions, agreements, joint ventures, partnerships, and acquisitions. Granular market information assembled in this Ankylosing Spondylitis report will be helpful to Medical Devices industry to take competent business decisions.

Market Drivers

Increasing cases of ankylosing spondylitis worldwide is the factor for the growth of this market
Rising research and development expenditure will also propel the growth of the market
Increasing number of population looking for solution for ankylosing spondylitis will also drive market growth
Development in healthcare industry will also drive market growth
Segmentation: Global Ankylosing Spondylitis (AS) Market

By Drug Type

Nonsteroidal Anti-Inflammatory Drugs
TNF Blockers
Immunosuppressive Drugs
Anti-Inflammatory Drugs
Steroids
JAK Inhibitors
Others
By Application

Juveniles
Adults
By Molecule

Biologics
Biosimilars
Small Molecules
By Route of Administration

Parenteral
Oral
By Geography

North America
Europe
Asia-Pacific
South America
Middle East and Africa
Get FREE TOC:- https://databridgemarketresearch.com/toc/?dbmr=global-ankylosing-spondylitis-as-market

Key Developments in the Market:

In December 2017, Izana Bioscience announced the launch of their new clinical-stage translational medicine company which will mainly concentrate on the development of namilumab in ankylosing spondylitis. The company also signed an agreement with Takeda Pharmaceutical Company Limited for the rights of manufacturing and commercialization of the product. The main aim of the launch is to provide better treatment and solutions to the people who are suffering from ankylosing spondylitis
In April 2016, FDA announced the approval of Inflectra / CT-P13, which is a biosimilar medication specially designed for ankylosing spondylitis and psoriatic arthritis. It is a reference product of an already approved product called Remicade. The main aim of the approval is to provide patient with more effective solution
Competitive Analysis:

Global ankylosing spondylitis (AS) market is highly fragmented and the major players have used various strategies such as new product launches, expansions, agreements, joint ventures, partnerships, acquisitions, and others to increase their footprints in this market. The report includes market shares of ankylosing spondylitis (AS) market for Global, Europe, North America, Asia-Pacific, South America and Middle East & Africa.

Key Market Competitors:

Few of the major competitors currently working in the global ankylosing spondylitis (AS) market are Merck & Co., Inc., AbbVie Inc., Reliance Life Sciences., Xian Janssen Pharmaceutical Ltd., Momenta Pharmaceuticals, Sandoz International GmbH, Pfizer Inc., Amgen Inc., Regeneron Pharmaceuticals, CELGENE CORPORATION, Trinity Biotech Ireland, Sanofi, Novartis AG, F. Hoffmann-La Roche Ltd, Eisai Co., Ltd., Celltrion Inc., Boehringer Ingelheim International GmbH, Hetero, Izana Bioscience and others

To Inquire before Buy Complete Report Click Here @ https://databridgemarketresearch.com/inquire-before-buying/?dbmr=global-ankylosing-spondylitis-as-market

Primary Respondents

Demand Side: Doctors, Surgeons, Medical Consultants, Nurses, Hospital Buyers, Group Purchasing Organizations, Associations, Insurers, Medical Payers, Healthcare Authorities, Universities, Technical Writers, Scientists, Promoters, and Investors among others.

Supply Side: Product Managers, Marketing Managers, C-Level Executives, Distributors, Market Intelligence, and Regulatory Affairs Managers among others.

Reasons to Purchase this Report

Current and future of global ankylosing spondylitis (AS) market outlook in the developed and emerging markets
The segment that is expected to dominate the market as well as the segment which holds highest CAGR in the forecast period
Regions/Countries that are expected to witness the fastest growth rates during the forecast period
The latest developments, market shares, and strategies that are employed by the major market players

Contact Us

Data Bridge Market Research

US: +1 888 387 2818

UK: +44 208 089 1725

Hong Kong: +852 8192 7475
Mail: Corporatesales@databridgemarketresearch.com
https://databridgemarketresearch.com

About Us

Data Bridge Market Research is a versatile market research and consulting firm with over 500 analysts working in different industries. We have catered more than 40% of the fortune 500 companies globally and have a network of more than 5000+ clientele around the globe. Our coverage of industries include Medical Devices, Pharmaceuticals, Biotechnology, Semiconductors, Machinery, Information and Communication Technology, Automobiles and Automotive, Chemical and Material, Packaging, Food and Beverages, Cosmetics, Specialty Chemicals, Fast Moving Consumer Goods, Robotics, among many others.

Data Bridge adepts in creating satisfied clients who reckon upon our services and rely on our hard work with certitude. Get Customization and Discount on Report by emailing Corporatesales@databridgemarketresearch.com . We are content with our glorious 99.9 % client satisfying rate.

This release was published on openPR.

Permanent link to this press release:

Copy
Please set a link in the press area of your homepage to this press release on openPR. openPR disclaims liability for any content contained in this release.

You can edit or delete your press release Ankylosing Spondylitis (AS) Market – Key Players are Momenta Pharmaceuticals, Sandoz International GmbH, Pfizer Inc., Amgen Inc., Regeneron Pharmaceuticals, CELGENE CORPORATION here

News-ID: 1847868 • Views: 971

More Releases from Data Bridge Market Research

Coordinate Measuring Machine Market to See Major Growth by 2026 | Aberlink Ltd, …
The latest 100+ page survey report on Coordinate Measuring Machine Market is released by Data Bridge Market Research covering various players of the industry selected from global geographies like U.S., Canada, Germany, France, U.K., Italy, Russia, China, Japan, South Korea, India, Australia, Taiwan, Indonesia, Thailand, Malaysia, Philippines, Vietnam, Mexico, Brazil, Argentina, Turkey, Saudi Arabia & U.A.E. A perfect mix of quantitative & qualitative Market information highlighting developments, industry challenges that
Spend Analytics Market Know Factors Driving the Market to Record Growth with | I …
The latest 100+ page survey report on Spend Analytics Market is released by Data Bridge Market Research covering various players of the industry selected from global geographies like U.S., Canada, Germany, France, U.K., Italy, Russia, China, Japan, South Korea, India, Australia, Taiwan, Indonesia, Thailand, Malaysia, Philippines, Vietnam, Mexico, Brazil, Argentina, Turkey, Saudi Arabia & U.A.E. A perfect mix of quantitative & qualitative Market information highlighting developments, industry challenges that competitors
Big Data and Data Engineering Services Market May Set New Growth Story | Amazon …
The latest 100+ page survey report on Big Data and Data Engineering Services Market is released by Data Bridge Market Research covering various players of the industry selected from global geographies like U.S., Canada, Germany, France, U.K., Italy, Russia, China, Japan, South Korea, India, Australia, Taiwan, Indonesia, Thailand, Malaysia, Philippines, Vietnam, Mexico, Brazil, Argentina, Turkey, Saudi Arabia & U.A.E. A perfect mix of quantitative & qualitative Market information highlighting developments,
Digital Audio Workstation (DAWs) Market Know Factors Driving the Market to Recor …
The latest 100+ page survey report on Digital Audio Workstation (DAWs) Market is released by Data Bridge Market Research covering various players of the industry selected from global geographies like U.S., Canada, Germany, France, U.K., Italy, Russia, China, Japan, South Korea, India, Australia, Taiwan, Indonesia, Thailand, Malaysia, Philippines, Vietnam, Mexico, Brazil, Argentina, Turkey, Saudi Arabia & U.A.E. A perfect mix of quantitative & qualitative Market information highlighting developments, industry challenges

All 5 Releases


More Releases for Ankylosing

Ankylosing Spondylitis Market Shares, Strategies and Forecast Worldwide, 2017 - …
Ankylosing spondylitis is a systemic inflammatory disease that primarily affects the spine. In ankylosing spondylitis, the joints, ligaments, and spine become inflamed. The inflammation leads to pain and stiffness in the lower back of the body and progress into the upper spine, neck, and chest. The joints and bones (vertebrae) fuse together eventually, causing the spine to become rigid and inflexible. Fused spine is called as bamboo spine as it
Ankylosing Spondylitis Market : New Study Offers Insights for 2025
Ankylosing spondylitis is a systemic inflammatory disease that primarily affects the spine. In ankylosing spondylitis, the joints, ligaments, and spine become inflamed. The inflammation leads to pain and stiffness in the lower back of the body and progress into the upper spine, neck, and chest. The joints and bones (vertebrae) fuse together eventually, causing the spine to become rigid and inflexible. Fused spine is called as bamboo spine as it
Ankylosing Spondylitis Treatment Market Estimated to Reach Revenues by 2021
The exact cause of ankylosing spondylitis is still unknown; however, a genetic link has been observed in some cases. People suffering from ankylosing spondylitis carry a gene called HLA-B27. Ankylosing spondylitis can be diagnosed via X-rays of the back and pelvis; or by physical examination. Currently, a cure for ankylosing spondylitis is not available on the market; the available treatments mainly help reduce the discomfort caused by ankylosing spondylitis. Various
Ankylosing Spondylitis Market Shares, Strategies, and Forecasts 2017 to 2025
Ankylosing spondylitis is a systemic inflammatory disease that primarily affects the spine. In ankylosing spondylitis, the joints, ligaments, and spine become inflamed. The inflammation leads to pain and stiffness in the lower back of the body and progress into the upper spine, neck, and chest. The joints and bones (vertebrae) fuse together eventually, causing the spine to become rigid and inflexible. Fused spine is called as bamboo spine as it
Ankylosing Spondylitis Therapeutics Pipeline Analysis, 2017 by P&S Market Resear …
Ankylosing spondylitis is an idiopathic disease, associated with HLA-B27, IL23R and ERAP1 genes. Usually, fewer people get affected with ankylosing spondylitis irrespective of activation of genes. Blood test, X-ray test, Magnetic Resonance Imaging (MRI) and physical investigations are some of the ways to effectively diagnose the disease. The disease begins with the inflammation in joints in the vertebrae and pelvic bones and spine. The environmental factors are believed to be
2017 Study - Ankylosing Spondylitis (Bekhterev’s Disease) Market H1 Pipeline R …
Orbisreserach.Com Adds “H1 Ankylosing Spondylitis (Bekhterev’s Disease) Market Pipeline Review 2017 Trend Analysis Report Report” To Its Research Database Ankylosing Spondylitis (Bekhterev's Disease) - Pipeline Review, H1 2017, provides an overview of the Ankylosing Spondylitis (Bekhterev's Disease) (Musculoskeletal Disorders) pipeline landscape. Ankylosing spondylitis is a type of arthritis that affects the spine. Ankylosing spondylitis symptoms include pain and stiffness from the neck down to the lower back. The spine's bones (vertebrae) may